Cite
Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
MLA
Su, Yan-Dong, et al. “Establishment of a Bayesian Network Model to Predict the Survival of Malignant Peritoneal Mesothelioma Patients after Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy.” International Journal of Hyperthermia, vol. 40, no. 1, Jan. 2023, pp. 1–8. EBSCOhost, https://doi.org/10.1080/02656736.2023.2223374.
APA
Su, Y.-D., Zhao, X., Ma, R., Fu, Y.-B., Yang, Z.-R., Wu, H.-L., Yu, Y., Yang, R., Liang, X., Du, X.-M., Chen, Y., & Li, Y. (2023). Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. International Journal of Hyperthermia, 40(1), 1–8. https://doi.org/10.1080/02656736.2023.2223374
Chicago
Su, Yan-Dong, Xin Zhao, Ru Ma, Yu-Bin Fu, Zhi-Ran Yang, He-Liang Wu, Yang Yu, et al. 2023. “Establishment of a Bayesian Network Model to Predict the Survival of Malignant Peritoneal Mesothelioma Patients after Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy.” International Journal of Hyperthermia 40 (1): 1–8. doi:10.1080/02656736.2023.2223374.